New article in J. of General Internal Medicine calls for simplifying EHRs

At my January 31, 2018 Healthcare Renewal blog post "The inevitable downgrading of burdensome, destructive EHRs back to paper&document imaging" athttp://hcrenewal.blogspot.com/2018/01/the-inevitable-downgrading-of.html, I opined that the downgrading of the clinician-facing components of EHRs was essential and inevitable. A new editorial in the Journal of General Internal Medicine makes similar points:‚ÄčElectronic Health Records: a " Quadruple Win, " a " Quadruple Failure, " or Simply Time for a Reboot?Journal of General Internal MedicineMichael Hochman05 February 2018https://link.springer.com/article/10.1007%2Fs11606-018-4337-6 "Perhaps most importantly, there must be a dramatic and thoughtful simplification of EHR documentation templates: it should not take over 200 mouse clicks and more than 700 key strokes to complete one ambulatory encounter. "Indeed.And this statement, seen frequently at this site, also appears:" Put simply, EHRs must be redesigned around the needs of clinicians and patients rather than billers and administrators. "The article also makes many other points about the technology I've been writing about for decades, such as the now-obvious grossly exaggerated claims about benefits and cost savings, and others:... many of the predictions about the benefits of EHRs have yet to materialize to the extent predicted. Though EHRs have facilitated some substantial improvements —the ability for cl...
Source: Health Care Renewal - Category: Health Management Tags: healthcare IT simplification Journal of General Internal Medicine Michael Hochman Source Type: blogs

Related Links:

A phase 2a study provides preliminary evidence that EDAS surgery to reroute brain arteries, used to treat moyamoya disease, may also reduce recurrent stroke in patients with intracranial stenosis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
A Chicago-based medical startup that wants to stop migraines using a nasal spray received more funding this week to continue its research. Seurat Therapeutics, a biotech startup founded within the University of Chicago, received a $500,000 grant from the National Institute of Neurological Disorders and Stroke. The funding will help the startup continue testing its product, a nasal spray that aims to stop the cause of migraines. The funding comes after the company raised $750,000 in seed funding…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
A new study says that smoking marijuana could raise the risk for any stroke by 15 percent and 29 percent for an ischemic stroke -- the most common kind,
Source: WebMD Health - Category: Consumer Health News Source Type: news
Date: Friday, 11 30, 2018; Speaker: Lawrence Corey, M.D., President and Director Emeritus , Fred Hutchinson Cancer Research Center; Patricia Flatley Brennan, R.N., Ph.D, Director , National Library of Medicine; Carl W. Dieffenbach, Ph.D., Director, Division of AIDS; Maureen M. Goodenow, Ph.D., Director, Office of AIDS Reseach ; Avindra Nath, M.D., Senior Investigator, National Institute of Neurological Disorders and Stroke; Daniel Appella, Ph.D., Senior Investigator, National Institute of Diabetes and Digestive and Kidney Diseases; Dima Hammoud, M.D., Investigator , NIH Clinical Center; Building: Building 38A (Lister Hill National Center)
Source: NIH Calendar of Events - Category: American Health Source Type: events
Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure. With the approval, the Chicago-based company said that the device can now be used in patients not eligible for a transplant as a life-long implant. “We partner with physicians to holistically develop therapies that benefit patients and achieve better outcomes. The unique design of the HeartMate 3 LVAD—with its Full MagLev technology—takes an established innovation and improves upon it in meaningful ways to help people with...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news
Conditions:   Brain Ischemia;   Hemiplegic Patients With Stroke;   Image Science;   Electrophysiology of Neuromuscular;   Abdominal Acupuncture Interventions:   Other: Abdominal acupuncture;   Other: Sham abdominal acupuncture Sponsors:   Guangzhou University of Traditional Chinese Medicine;   Chinese University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hypertension;   Stroke;   Blood Pressure, High;   Systolic Hypertension;   Transient Ischemic Attack;   Cerebrovascular Accident Intervention:   Combination Product: TEC4Home Stroke Cohort Sponsors:   Vancouver Coastal Health Research Institute;   VGH and UBC Hospital Foundation;   Vancouver General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Rehabilitation, Tenodesis, Stroke Intervention:   Other: Motor task specific training Sponsor:   National Cheng-Kung University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Embolic Stroke of Undetermined Source Intervention:   Sponsors:   University of British Columbia;   Boehringer Ingelheim Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
PMID: 30328396 [PubMed - in process]
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Neuropharmacol Source Type: research
More News: Blogging | Electronic Health Records (EHR) | Health Management | Information Technology | Internal Medicine | Stroke | Warnings